Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 249443 who wrote (77)	7/8/2002 12:00:57 PM
From: AurumRabosa	of 684

"Genetics and genomics will play a major role in the future of the healthcare industry," said Alen Roses, head of genetics research at GlaxoSmithKline. Over the next two to five years, the biggest use of genetic information will likely be to create genetic profiles to establish who is most likely to benefit from existing drugs and who is most liable to suffer a potentially serious side effect, he said. "Creating safer products is becoming even more necessary if they are to compete in this highly regulated market," Roses said. So can this be construed as a plug for the technology VGNX is developing?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next